Neomend
Irvine · Founded 1999
About Neomend
Neomend is a biomedical device company that engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in the commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally invasive/laparoscopic procedures.
Company Facts
- Founded: 1999
- Legal name: Neomend, Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $61.7M
- Funding stage: M&A
- Last round: Series D (Aug 2011)
- Website: neomend.com
- Phone: +1 949 783 3334
Social Profiles
Canonical: https://fsome.com/organization/neomend-8412669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.